Last updated: December 30, 2022
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
4
Condition
Anesthesia
Treatment
N/AClinical Study ID
NCT05655806
N-56-2022/MD
Ages 21-50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: ASA I-II. 20-50 years old patients. Both sexes Patients undergoing single or double levellumbar laminectomy ,discectomy and/or fixation
Exclusion
Exclusion Criteria: Contraindications to the use of aminophylline as cardiac patients, patients with renalimpairment, hepatic dysfunction, hypo or hyperthyroidism and epilepsy. Patients who have hypersensitivity to aminophylline Emergency operations. Operative timeexceeding 5 hours
Study Design
Total Participants: 33
Study Start date:
December 30, 2022
Estimated Completion Date:
July 30, 2023
Study Description
Connect with a study center
Kasr Alainy
Cairo, 11562
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.